CA2153787A1 - Solution renfermant igf-1 - Google Patents
Solution renfermant igf-1Info
- Publication number
- CA2153787A1 CA2153787A1 CA002153787A CA2153787A CA2153787A1 CA 2153787 A1 CA2153787 A1 CA 2153787A1 CA 002153787 A CA002153787 A CA 002153787A CA 2153787 A CA2153787 A CA 2153787A CA 2153787 A1 CA2153787 A1 CA 2153787A1
- Authority
- CA
- Canada
- Prior art keywords
- igf
- mmol
- formulation
- relates
- buffer substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101150088952 IGF1 gene Proteins 0.000 title 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract 4
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 4
- 239000012928 buffer substance Substances 0.000 abstract 3
- 238000009472 formulation Methods 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 239000000243 solution Substances 0.000 abstract 3
- 229910019142 PO4 Inorganic materials 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 2
- 239000010452 phosphate Substances 0.000 abstract 2
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000007951 isotonicity adjuster Substances 0.000 abstract 1
- 238000010254 subcutaneous injection Methods 0.000 abstract 1
- 239000007929 subcutaneous injection Substances 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9300105A SE9300105D0 (sv) | 1993-01-15 | 1993-01-15 | Stable protein solution |
| SESE9300105-5 | 1993-01-15 | ||
| PCT/SE1994/000010 WO1994015584A1 (fr) | 1993-01-15 | 1994-01-10 | Solution contenant l'igf-1 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2153787A1 true CA2153787A1 (fr) | 1994-07-21 |
| CA2153787C CA2153787C (fr) | 2005-11-15 |
Family
ID=35520888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002153787A Expired - Fee Related CA2153787C (fr) | 1993-01-15 | 1994-01-10 | Solution renfermant igf-1 |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2153787C (fr) |
-
1994
- 1994-01-10 CA CA002153787A patent/CA2153787C/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2153787C (fr) | 2005-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0747092A3 (fr) | Fluide dissolvant pour médicaments administrés par iontophorèse | |
| CS590188A2 (en) | Method of erythropoietin's stabilized preparation production | |
| GR3030383T3 (en) | Solution containing igf-1. | |
| HK1107103A1 (en) | Purification and stabilization of peptide and proteins in pharmaceutical agents | |
| MX9802734A (es) | Nuevas formulaciones liquidas estables a base de paracetamol y su modo de preparacion. | |
| WO2000043034A3 (fr) | Formulations d'analogues d'insuline acyles hexameres monodisperses | |
| SG48704A1 (en) | Improved amino acid solutions for treatment of peritoneal dialysis patients | |
| CA2183755A1 (fr) | Preparation pharmaceutique contenant des activateurs du plasminogene | |
| AU3226984A (en) | Aqueous, injectable solutions of cis-platimum | |
| AU9468998A (en) | Concentrate for medical solution and use thereof | |
| CA2153787A1 (fr) | Solution renfermant igf-1 | |
| EP0315118A3 (fr) | ADN codant pour endothéline et son utilisant | |
| MX9700967A (es) | Uso terapeutico de acetazolamida para el tratamiento de edema cerebral. | |
| GR3036481T3 (en) | Medicament containing delta-aminolevulinic acid | |
| CA2132664A1 (fr) | Traitement chimique pour ameliorer la permeabilite d'un gisement d'hydrocarbures renfermant du pyrobitume | |
| DE69027441D1 (en) | Ribozymenhemmer | |
| AU1022688A (en) | Antibacterial lyophilized preparation | |
| US5204091A (en) | Method for combatting foot odors | |
| WO1996020702B1 (fr) | Utilisation d'acide 2,3-alkylcarbonyloxybenzoique pour traiter le syndrome de souffrance respiratoire chez l'adulte | |
| CA2165271A1 (fr) | Reduction du tissu adipeux | |
| Babu et al. | Effect of non-protein nitrogen on nitrogenous end products of the fish Cyprinus carpio | |
| CA2405265A1 (fr) | Procede de prevention ou de traitement du diabete | |
| SU1616667A1 (ru) | Способ профилактики кариеса зубов | |
| AU2357992A (en) | Use of combination of a gel and a solution both containing an organic acid for cleaning dentures | |
| JPS6466130A (en) | High polymer carcinostatic enhancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |